Monkeypox virus: An emerging epidemic
- PMID: 36179973
- PMCID: PMC9534103
- DOI: 10.1016/j.micpath.2022.105794
Monkeypox virus: An emerging epidemic
Abstract
Introduction: A monkeypox outbreak is spreading in territories where the virus is not generally prevalent. The rapid and sudden emergence of monkeypox in numerous nations at the same time means that unreported transmission may have persisted. The number of reported cases is on a constant increase worldwide. At least 20 non-African countries, like Canada, Portugal, Spain, and the United Kingdom, have reported more than 57662 as of September 9th suspected or confirmed cases. This is the largest epidemic seen outside of Africa. Scientists are struggling to determine the responsible genes for the higher virulence and transmissibility of the virus. Because the viruses are related, several countries have begun acquiring smallpox vaccinations, which are believed to be very effective against monkeypox.
Methods: Bibliographic databases and web-search engines were used to retrieve studies that assessed monkeypox basic biology, life cycle, and transmission. Data were evaluated and used to explain the therapeutics that are under use or have potential. Finally, here is a comparison between how vaccines are being made now and how they were made in the past to stop the spread of new viruses.
Conclusions: Available vaccines are believed to be effective if administered within four days of viral exposure, as the virus has a long incubation period. As the virus is zoonotic, there is still a great deal of concern about the viral genetic shift and the risk of spreading to humans. This review will discuss the virus's biology and how dangerous it is. It will also look at how it spreads, what vaccines and treatments are available, and what technologies could be used to make vaccines quickly using mRNA technologies.
Keywords: Epidemic; Infectious pathogens; Monkeypox; Outbreak; Outbreak investigation; Transmission.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Outbreaks of human monkeypox after cessation of smallpox vaccination.Trends Microbiol. 2012 Feb;20(2):80-7. doi: 10.1016/j.tim.2011.12.001. Epub 2012 Jan 10. Trends Microbiol. 2012. PMID: 22239910 Review.
-
State-of-the-art on monkeypox virus: an emerging zoonotic disease.Infection. 2022 Dec;50(6):1425-1430. doi: 10.1007/s15010-022-01935-3. Epub 2022 Oct 3. Infection. 2022. PMID: 36192607 Review.
-
Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Int J Infect Dis. 2019. PMID: 30453097 Free PMC article. Review.
-
Monkeypox virus vaccine evolution and global preparedness for vaccination.Int Immunopharmacol. 2022 Dec;113(Pt A):109346. doi: 10.1016/j.intimp.2022.109346. Epub 2022 Oct 20. Int Immunopharmacol. 2022. PMID: 36274490 Free PMC article.
-
Monkeypox: An international epidemic.Rev Med Virol. 2022 Nov;32(6):e2392. doi: 10.1002/rmv.2392. Epub 2022 Aug 27. Rev Med Virol. 2022. PMID: 36029181 Review.
Cited by
-
An Epidemiological and Clinical Study of Monkeypox in Changsha, China: A Retrospective Analysis of HIV-Infected and Non-HIV-Infected Patients from June to December 2023.Infect Drug Resist. 2024 Nov 29;17:5305-5313. doi: 10.2147/IDR.S485232. eCollection 2024. Infect Drug Resist. 2024. PMID: 39628830 Free PMC article.
-
Exploring monkeypox virus antibody levels: insights from human immunological research.Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0. Virol J. 2025. PMID: 40450351 Free PMC article. Review.
-
The monkeypox virus-host interplays.Cell Insight. 2024 Jul 14;3(5):100185. doi: 10.1016/j.cellin.2024.100185. eCollection 2024 Oct. Cell Insight. 2024. PMID: 39144256 Free PMC article. Review.
-
Identification of novel potential inhibitors of monkeypox virus thymidine kinase using molecular docking, molecular dynamics simulation and MM/PBSA methods.Mol Divers. 2024 Aug;28(4):2513-2546. doi: 10.1007/s11030-023-10692-w. Epub 2023 Jul 18. Mol Divers. 2024. PMID: 37462851
-
Exploring Monkeypox: prospects for therapeutics through computational-aided drug discovery.Mol Divers. 2024 Oct;28(5):3497-3521. doi: 10.1007/s11030-023-10767-8. Epub 2023 Dec 11. Mol Divers. 2024. PMID: 38079063 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous